NPI: 1235213463 · FRENCH CAMP, CA 95231 · 261QE0700X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 3,515 | $327K |
| 2019 | 8,453 | $411K |
| 2020 | 30,538 | $872K |
| 2021 | 50,836 | $2.06M |
| 2022 | 56,307 | $3.11M |
| 2023 | 67,091 | $3.43M |
| 2024 | 24,067 | $829K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | 61,235 | 5,055 | $5.55M | |
| J0882 | Darbepoetin alfa, esrd use | 12,646 | 3,416 | $2.53M |
| J0606 | Inj, etelcalcetide, 0.1 mg | 15,696 | 1,320 | $1.93M |
| J1756 | Iron sucrose injection | 7,744 | 1,495 | $292K |
| J1644 | Inj heparin sodium per 1000u | 26,936 | 2,764 | $283K |
| 0250 | 77,438 | 3,577 | $228K | |
| 82728 | 4,541 | 4,354 | $35K | |
| J3490 | Drugs unclassified injection | 3,935 | 264 | $35K |
| 85027 | 8,796 | 4,332 | $34K | |
| 83970 | 1,838 | 1,762 | $28K | |
| 80069 | 3,582 | 3,218 | $22K | |
| 83550 | 4,532 | 4,347 | $21K | |
| 86803 | 779 | 745 | $6K | |
| 80061 | 769 | 739 | $6K | |
| 87340 | 1,009 | 958 | $6K | |
| U0003 | Cov-19 amp prb hgh thruput | 76 | 44 | $5K |
| 86706 | 837 | 802 | $5K | |
| 86481 | 112 | 86 | $4K | |
| 90686 | 182 | 180 | $4K | |
| 84520 | 2,996 | 2,305 | $4K | |
| 83036 | 989 | 909 | $4K | |
| 82948 | 1,551 | 236 | $3K | |
| 90746 | 12 | 12 | $2K | |
| 84100 | 489 | 421 | $2K | |
| 82565 | 415 | 281 | $1K | |
| J1580 | Garamycin gentamicin inj | 153 | 14 | $1K |
| T1999 | Noc retail items andsupplies | 207 | 20 | $1K |
| 85045 | 378 | 342 | $923.33 | |
| 82310 | 207 | 190 | $731.31 | |
| 85610 | 215 | 177 | $599.89 | |
| 85025 | 88 | 77 | $541.24 | |
| 87521 | Neg quan hep c or qual rna | 12 | 12 | $374.31 |
| 83540 | 253 | 242 | $314.48 | |
| 84132 | 92 | 86 | $271.36 | |
| 85730 | 15 | 12 | $64.14 | |
| 90656 | 25 | 25 | $58.99 | |
| 83721 | 27 | 27 | $40.15 |